Polaroid Therapeutics Receives CE Mark for Novel Antimicrobial Wound Dressing POLTX_Fiber
核心洞察
Polaroid Therapeutics (搜索) has received CE Mark approval for POLTX_Fiber (搜索), the first wound care dressing to incorporate their novel Antimicrobial Polymer Technology (搜索) (APT (搜索)) platform.
The Class IIb medical device prevents bacterial colonization within the dressing without contributing to antimicrobial resistance, addressing a critical challenge in modern wound care.
POLTX_Fiber (搜索) is indicated for moderate to heavily exuding wounds (搜索) including leg ulcers (搜索), pressure ulcers (搜索), diabetic ulcers (搜索), and surgical wounds (搜索).
Polaroid Therapeutics (搜索) (PTx (搜索)) announced that its antimicrobial wound dressing POLTX_Fiber (搜索) has received CE Mark certification as a Class IIb medical device, marking the Swiss biotech's entry into the wound care sector with its novel Antimicrobial Polymer Technology (搜索) (APT (搜索)) platform. The approval, granted by TÜV Süd on February 23, 2026, under MDR 2017/745, represents a significant milestone for the company founded in 2022.
Revolutionary Antimicrobial Technology
POLTX_Fiber (搜索) introduces APT (搜索), a platform that enables controlled antimicrobial performance through structural design rather than chemical release. Unlike conventional antimicrobial wound dressings that release antimicrobial components and may expose patients to known side effects, APT is designed to act rapidly and provide sustained activity to prevent bacterial colonization within the dressing without contributing to antimicrobial resistance.
"POLTX_Fiber (搜索) is the first medical device to introduce our APT (搜索) platform, incorporating new antimicrobial polymer technology (搜索) that meets the highest standards, while responding to the real challenges of modern wound care," said Ran Frenkel, Co-founder and CEO of PTx (搜索). "Its certification now offers new options in wound care, and we believe we are setting a new standard of care and protection."
Product Design and Clinical Applications
The wound dressing is constructed as a soft, conformable non-woven material made of sodium carboxymethylcellulose (CMC) fibers and strengthening cellulose fibers that integrates the newly developed APT (搜索) technology. When in contact with wound exudate, the dressing forms a gel that helps maintain a moist wound environment, supports autolytic debridement, and protects the wound edge and surrounding skin from maceration.
POLTX_Fiber (搜索) is indicated for use under healthcare professional supervision for managing various wound types, including:
- Wounds with moderate to heavy exudate
- Acute or chronic wounds
- Leg ulcers, pressure ulcers (stage II to IV), and diabetic ulcers
- Surgical wounds, including post-operative wounds, donor sites, and wounds left to heal by secondary intent
- Traumatic wounds such as abrasions and lacerations
- Exuding oncology wounds
- Superficial or cavity wounds
Market Launch and Future Development
Following the CE Mark approval, PTx (搜索) has begun preparations for introducing POLTX_Fiber (搜索) in selected European markets, collaborating with clinicians, wound care centers, and distribution partners to generate clinical and patient experience data. The company manufactures the product under ISO 13485 quality requirements.
POLTX_Fiber (搜索) represents the first step in a broader APT (搜索)-powered portfolio, with additional medical devices in development to extend the platform across various wound care applications. The technology platform integrates proprietary polymer chemistry that can be adapted across multiple formats and clinical contexts, reflecting the company's focus on responsible innovation and long-term antimicrobial resistance stewardship.
Company Background
Polaroid Therapeutics (搜索) is a Swiss-based biotech startup incubated and developed by Polaroid, the brand known for pioneering instant photography technology. The company's mission centers on creating human-centric medical solutions based on advancements in science and technology, with APT (搜索) representing their core platform for controlled antimicrobial performance through structural design rather than chemical release.